A Novel Immunofluorescence Assay for the Rapid Serological Detection of SARS-CoV-2 Infection

As of April 2021, the COVID-19 pandemic has swept through 213 countries and infected more than 132 million individuals globally, posing an unprecedented threat to human health. There are currently no specific antiviral treatments for COVID-19 and vaccination programmes, whilst promising, remain in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Dung, Skelly, Donal, Goonawardane, Niluka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146438/
https://www.ncbi.nlm.nih.gov/pubmed/33923271
http://dx.doi.org/10.3390/v13050747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146438/
https://www.ncbi.nlm.nih.gov/pubmed/33923271
http://dx.doi.org/10.3390/v13050747

Ejemplares similares